DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CDP-860
2
Antibody
Investigational
Unknown
Unknown
Unknown
Platelet-derived growth factor receptor beta inhibitor
CDP-860
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLORBENAZINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLORBENAZINE
×
Maximum Phase:
2
First Approval:
None
UNII:
K5GDY88W5X
Molecule Type:
Small molecule
Molecular Formula:
C21H32FNO3
Molecular Weight:
365.49
AlogP:
3.76
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
PIRITREXIM
2
Small molecule
Investigational
Unknown
Unknown
Urethral Neoplasms; Urinary Bladder Neoplasms
Dihydrofolate reductase inhibitor
PIRITREXIM
×
Maximum Phase:
2
First Approval:
None
UNII:
MK2A783ZUT
Molecule Type:
Small molecule
Molecular Formula:
C17H19N5O2
Molecular Weight:
325.37
AlogP:
2.11
PSA:
109.17
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TEGOBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
TEGOBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
5NOK5X389M
Molecule Type:
Small molecule
Molecular Formula:
C25H14F7N5
Molecular Weight:
517.41
AlogP:
6.73
PSA:
56.49
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ETAVOPIVAT
2
Small molecule
Investigational
Unknown
Unknown
Anemia, Sickle Cell
Unknown
ETAVOPIVAT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H23N3O6S
Molecular Weight:
457.51
AlogP:
0.77
PSA:
109.27
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TESNATILIMAB
2
Antibody
Investigational
Unknown
Unknown
Alopecia Areata; Crohn Disease
Unknown
TESNATILIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
2B860WP9F0
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHF6001
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CHF6001
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MM-111
2
Unknown
Investigational
Unknown
Unknown
Breast Neoplasms
ErbB-2/ErbB-3 heterodimer inhibitor
MM-111
×
Maximum Phase:
2
First Approval:
None
UNII:
6IJ4CQY76O
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EGANELISIB
2
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase p110-gamma subunit inhibitor
EGANELISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
FOF5155FMZ
Molecule Type:
Small molecule
Molecular Formula:
C30H24N8O2
Molecular Weight:
528.58
AlogP:
3.24
PSA:
125.13
HBD:
2.0
HBA:
#RotB:
4.0
Source:
EPELSIBAN BESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EPELSIBAN BESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H629P9T4UN
Molecule Type:
Small molecule
Molecular Formula:
C36H44N4O7S
Molecular Weight:
676.84
AlogP:
2.76
PSA:
91.84
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AZD1446
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Attention Deficit Disorder with Hyperactivity
Neuronal acetylcholine receptor; alpha4/beta2 agonist
AZD1446
×
Maximum Phase:
2
First Approval:
None
UNII:
ANR9OP1V17
Molecule Type:
Small molecule
Molecular Formula:
C11H13ClN2O2
Molecular Weight:
240.69
AlogP:
1.22
PSA:
45.48
HBD:
1.0
HBA:
#RotB:
1.0
Source:
HYDROXYPROGESTERONE
2
Small molecule
Investigational
Unknown
Unknown
Premature Birth
Unknown
HYDROXYPROGESTERONE
×
Maximum Phase:
2
First Approval:
None
UNII:
21807M87J2
Molecule Type:
Small molecule
Molecular Formula:
C21H30O3
Molecular Weight:
330.47
AlogP:
3.84
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
MARALIXIBAT CHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Cholangitis, Sclerosing; Liver Cirrhosis, Biliary; Alagille Syndrome; Pruritus
Ileal bile acid transporter inhibitor
MARALIXIBAT CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
V78M04F0XC
Molecule Type:
Small molecule
Molecular Formula:
C40H56ClN3O4S
Molecular Weight:
710.42
AlogP:
6.62
PSA:
70.08
HBD:
1.0
HBA:
#RotB:
13.0
Source:
HQP1351
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HQP1351
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HP184
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HP184
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REVAPRAZAN
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Unknown
REVAPRAZAN
×
Maximum Phase:
2
First Approval:
None
UNII:
5P184180P5
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN4
Molecular Weight:
362.45
AlogP:
5.1
PSA:
41.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CTS-1027
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Unknown
CTS-1027
×
Maximum Phase:
2
First Approval:
None
UNII:
2QD3F58224
Molecule Type:
Small molecule
Molecular Formula:
C19H20ClNO6S
Molecular Weight:
425.89
AlogP:
3.21
PSA:
101.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TAK-448
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Hypogonadism
Unknown
TAK-448
×
Maximum Phase:
2
First Approval:
None
UNII:
YO029HR229
Molecule Type:
Small molecule
Molecular Formula:
C58H80N16O14
Molecular Weight:
1225.38
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PRS-211375
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB2 receptor agonist
PRS-211375
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOCIPARSTAT SODIUM
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOCIPARSTAT SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
4O75889WF4
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
9-AMINOCAMPTOTHECIN
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Esophageal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms
Unknown
9-AMINOCAMPTOTHECIN
×
Maximum Phase:
2
First Approval:
None
UNII:
5MB77ICE2Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17N3O4
Molecular Weight:
363.37
AlogP:
1.66
PSA:
107.44
HBD:
2.0
HBA:
#RotB:
1.0
Source:
SOTB07
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SOTB07
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VESTIPITANT MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurokinin 1 receptor antagonist
VESTIPITANT MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
OWR424W90Q
Molecule Type:
Small molecule
Molecular Formula:
C24H28F7N3O4S
Molecular Weight:
587.56
AlogP:
5.93
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BATEFENTEROL
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
BATEFENTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
1IAT42T80T
Molecule Type:
Small molecule
Molecular Formula:
C40H42ClN5O7
Molecular Weight:
740.26
AlogP:
6.43
PSA:
165.25
HBD:
6.0
HBA:
#RotB:
13.0
Source:
GW-274150
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Arthritis, Rheumatoid; Migraine Disorders
Nitric oxide synthase, inducible inhibitor
GW-274150
×
Maximum Phase:
2
First Approval:
None
UNII:
0ZZF1V8G63
Molecule Type:
Small molecule
Molecular Formula:
C8H17N3O2S
Molecular Weight:
219.31
AlogP:
0.11
PSA:
99.2
HBD:
4.0
HBA:
#RotB:
7.0
Source:
IBUDILAST
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies; Glioblastoma; Migraine Disorders; Pain; Substance-Related Disorders; Alcoholism; Amphetamine-Related Disorders; Amyotrophic Lateral Sclerosis; Multiple Sclerosis, Chronic Progressive; Opioid-Related Disorders; Pneumonia, Viral; Lung Diseases, Obstructive; Spinal Cord Diseases
Phosphodiesterase 10A inhibitor
IBUDILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
M0TTH61XC5
Molecule Type:
Small molecule
Molecular Formula:
C14H18N2O
Molecular Weight:
230.31
AlogP:
3.3
PSA:
34.37
HBD:
0.0
HBA:
#RotB:
3.0
Source:
BATABULIN
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
BATABULIN
×
Maximum Phase:
2
First Approval:
None
UNII:
T4NP8G3K6Q
Molecule Type:
Small molecule
Molecular Formula:
C13H7F6NO3S
Molecular Weight:
371.26
AlogP:
3.33
PSA:
55.4
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IBEZAPOLSTAT
2
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections
Unknown
IBEZAPOLSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
5K543KNC5P
Molecule Type:
Small molecule
Molecular Formula:
C18H20Cl2N6O2
Molecular Weight:
423.3
AlogP:
2.37
PSA:
88.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VRC-01LS
2
Unknown
Investigational
Unknown
Unknown
HIV Infections
T-cell surface antigen CD4 binding agent
VRC-01LS
×
Maximum Phase:
2
First Approval:
None
UNII:
6JM4WD2J1A
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NS-2359
2
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Depressive Disorder
Monoamine transporter inhibitor
NS-2359
×
Maximum Phase:
2
First Approval:
None
UNII:
76H76554PA
Molecule Type:
Small molecule
Molecular Formula:
C16H21Cl2NO
Molecular Weight:
314.26
AlogP:
4.21
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
F18-FFNP
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
F18-FFNP
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUBENTYLOSIN
2
Small molecule
Investigational
Unknown
Unknown
Onchocerciasis
Unknown
FLUBENTYLOSIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C53H82FNO17
Molecular Weight:
1024.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
L-NAME
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Asthma
Unknown
L-NAME
×
Maximum Phase:
2
First Approval:
None
UNII:
V55S2QJN2X
Molecule Type:
Small molecule
Molecular Formula:
C7H15N5O4
Molecular Weight:
233.23
AlogP:
-1.43
PSA:
143.37
HBD:
4.0
HBA:
#RotB:
6.0
Source:
CC-115
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Squamous Cell; Glioblastoma; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Metastasis; Osteosarcoma; Prostatic Neoplasms, Castration-Resistant
DNA-dependent protein kinase inhibitor
CC-115
×
Maximum Phase:
2
First Approval:
None
UNII:
FII75TFH5L
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PBF-680
2
Small molecule
Investigational
Unknown
Unknown
Asthma
Adenosine A1 receptor antagonist
PBF-680
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
153
154
155
156
157
158
159
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA